BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 22417010)

  • 1. Human T-cell leukemia virus type 1 infection worsens prognosis of hepatitis C virus-related living donor liver transplantation.
    Ichikawa T; Taura N; Miyaaki H; Matsuzaki T; Ohtani M; Eguchi S; Takatsuki M; Soyama A; Hidaka M; Okudaira S; Usui T; Mori S; Kamihira S; Kanematsu T; Nakao K
    Transpl Int; 2012 Apr; 25(4):433-8. PubMed ID: 22417010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcome of hepatitis C infection after liver transplantation.
    Gane EJ; Portmann BC; Naoumov NV; Smith HM; Underhill JA; Donaldson PT; Maertens G; Williams R
    N Engl J Med; 1996 Mar; 334(13):815-20. PubMed ID: 8596547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients.
    Guo L; Orrego M; Rodriguez-Luna H; Balan V; Byrne T; Chopra K; Douglas DD; Harrison E; Moss A; Reddy KS; Williams JW; Rakela J; Mulligan D; Vargas HE
    Liver Transpl; 2006 Apr; 12(4):560-5. PubMed ID: 16555313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody to the human T-lymphotropic virus type 1 (HTLV-1) envelope protein Gp46 in patients co-infected with HCV and HTLV-1.
    Takeoka H; Furusyo N; Toyoda K; Murata M; Sagara Y; Kashiwagi S; Hayashi J
    Am J Trop Med Hyg; 2007 Jul; 77(1):192-6. PubMed ID: 17620653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human T lymphotropic virus type 1 infection influences hepatitis C virus clearance.
    Kishihara Y; Furusyo N; Kashiwagi K; Mitsutake A; Kashiwagi S; Hayashi J
    J Infect Dis; 2001 Nov; 184(9):1114-9. PubMed ID: 11598833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of liver transplantation for recipients with hepatitis B and hepatitis C virus coinfection: analysis of the UNOS data.
    Waki K; Sugawara Y; Tamura S; Mieno MN; Yamashiki N; Kadowaki T; Kokudo N
    Transplantation; 2011 Oct; 92(7):809-14. PubMed ID: 21832961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation.
    Thuluvath PJ; Yoo HY
    Liver Transpl; 2004 Oct; 10(10):1263-8. PubMed ID: 15376301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of human T-cell leukemia virus type 1 on living donor liver transplantation: a multi-center study in Japan.
    Yoshizumi T; Takada Y; Shirabe K; Kaido T; Hidaka M; Honda M; Ito T; Shinoda M; Ohdan H; Kawagishi N; Sugawara Y; Ogura Y; Kasahara M; Kubo S; Taketomi A; Yamashita N; Uemoto S; Yamaue H; Miyazaki M; Takada T; Maehara Y
    J Hepatobiliary Pancreat Sci; 2016 Jun; 23(6):333-41. PubMed ID: 26996829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of living donor liver transplantation for hepatitis C virus (HCV)-positive patients.
    Takada Y; Haga H; Ito T; Nabeshima M; Ogawa K; Kasahara M; Oike F; Ueda M; Egawa H; Tanaka K
    Transplantation; 2006 Feb; 81(3):350-4. PubMed ID: 16477219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts.
    Khapra AP; Agarwal K; Fiel MI; Kontorinis N; Hossain S; Emre S; Schiano TD
    Liver Transpl; 2006 Oct; 12(10):1496-503. PubMed ID: 16964597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United States.
    Russo MW; Galanko J; Beavers K; Fried MW; Shrestha R
    Liver Transpl; 2004 Mar; 10(3):340-6. PubMed ID: 15004758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes of orthotopic liver transplantation in human immunodeficiency virus-infected patients and comparison with human immunodeficiency virus-negative cases.
    Baccarani U; Adani GL; Bragantini F; Londero A; Comuzzi C; Rossetto A; Lorenzin D; Bresadola V; Risaliti A; Pea F; Toniutto P; Donini A; De Anna D; Bresadola F; Tavio M; Viale P
    Transplant Proc; 2011 May; 43(4):1119-22. PubMed ID: 21620067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated hepatitis C virus kinetics but similar survival rates in recipients of liver grafts from living versus deceased donors.
    Schiano TD; Gutierrez JA; Walewski JL; Fiel MI; Cheng B; Bodenheimer H; Thung SN; Chung RT; Schwartz ME; Bodian C; Branch AD
    Hepatology; 2005 Dec; 42(6):1420-8. PubMed ID: 16317672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of donor variables on the outcome of orthotopic liver transplantation for hepatitis C.
    Yagci G; Fernandez LA; Knechtle SJ; D'Alessandro AM; Chin LT; Musat AI; Lucey MR; Said A; Pirsch JD; Leverson G; Kalayoglu M
    Transplant Proc; 2008; 40(1):219-23. PubMed ID: 18261591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of living donor liver transplantation for Egyptian patients with hepatitis C (genotype 4)-related cirrhosis.
    Yosry A; Esmat G; El-Serafy M; Omar A; Doss W; Said M; Abdel-Bary A; Hosny A; Marawan I; El-Malt O; Kamel RR; Hatata Y; Ghali A; Sabri H; Kamel S; El-Gbaly H; Tanaka K
    Transplant Proc; 2008 Jun; 40(5):1481-4. PubMed ID: 18589133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of patient and graft survival following liver transplantation for hepatitis C.
    Charlton M; Seaberg E; Wiesner R; Everhart J; Zetterman R; Lake J; Detre K; Hoofnagle J
    Hepatology; 1998 Sep; 28(3):823-30. PubMed ID: 9731579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid-free living donor liver transplantation in adults: impact on hepatitis C recurrence.
    Marubashi S; Dono K; Nagano H; Kim C; Asaoka T; Hama N; Kobayashi S; Takeda Y; Umeshita K; Monden M; Doki Y; Mori M
    Clin Transplant; 2009; 23(6):904-13. PubMed ID: 19573088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia.
    Zhou S; Terrault NA; Ferrell L; Hahn JA; Lau JY; Simmonds P; Roberts JP; Lake JR; Ascher NL; Wright TL
    Hepatology; 1996 Nov; 24(5):1041-6. PubMed ID: 8903372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.